$JNJ Recent Headlines J&J to call for voluntar
Post# of 145207
Posted On: 08/01/2014 11:04:24 AM
$JNJ Recent Headlines
J&J to call for voluntary return of morcellators 5:30 p.m. July 30, 2014 - MarketWatch.com
Chipotle tops S&P 500, Herbalife ignores ‘death blow’ 1:14 p.m. July 22, 2014 - MarketWatch
Johnson & Johnson sets $5 billion share buyback 5:20 p.m. July 21, 2014 - Jim Jelter
Two rules of thumb for dumping your financial adviser 2:36 p.m. July 18, 2014 - Mark Hulbert
Dow ekes out a gain, but S&P falls; Yellen knocks biotechs and social media: live blog recap 3:04 p.m. July 15, 2014 - blogs.marketwatch.com
Johnson & Johnson shares dip on cautious outlook 10:55 a.m. July 15, 2014 - blogs.marketwatch.com
Plug Power rallies; Lorillard drops on Reynolds merger 10:40 a.m. July 15, 2014 - Angela Johnson
Newscast: NBA wants to double TV fees 9:59 a.m. July 15, 2014 - MarketWatch
Johnson & Johnson tops forecasts, boosts outlook 7:57 a.m. July 15, 2014 - MarketWatch.com
Johnson & Johnson shares up 0.4% in premarket trade 7:51 a.m. July 15, 2014 - Tomi Kilgore
Johnson & Johnson sees full-year 2014 adjusted EPS of $5.85 to $5.92 7:50 a.m. July 15, 2014 - William L. Watts
Johnson & Johnson Q2 sales up 9.1% to $19.5 billion 7:49 a.m. July 15, 2014 - William L. Watts
Johnson & Johnson Q2 adjusted EPS $1.66 7:49 a.m. July 15, 2014 - William L. Watts
Johnson & Johnson Q2 EPS $1.51 vs. $1.33 a year earlier 7:47 a.m. July 15, 2014 - William L. Watts
The market in a minute: Earnings over politics 10:56 a.m. July 14, 2014 - The Trading Deck
Tech, bank earnings to test economic recovery 6:01 a.m. July 13, 2014 - Wallace Witkowski
Wal-Mart embracing smaller stores in growth strategy 4:05 a.m. July 8, 2014 - Shelly Banjo
How to buy momentum stocks without getting burned 9:22 a.m. July 7, 2014 - Jonathan Burton
What GM could gain from the recall of 29 million cars 4:54 a.m. July 4, 2014 - Tim Mullaney
Whistleblower to get millions for speaking up 8:00 a.m. June 25, 2014 - Al Lewis
Retirement Strategy: Buy The Dips Portfolio Update With Some Stocks On Sale 9:24 a.m. Today - Seeking Alpha
Dividend Investing Over The Past 7 Years Was Never Easy 12:14 a.m. Today - Seeking Alpha
NuVasive Running On Renewed MIS Vigor 12:04 p.m. July 31, 2014 - Seeking Alpha
Bayer Earnings Grow Marginally Y/Y, New Products Encourage - Analyst Blog 10:41 a.m. July 31, 2014 - Zacks.com
Why Johnson & Johnson (JNJ) Stock Is Lower Today 8:37 a.m. July 31, 2014 - TheStreet.com
The 10-Point: Gerard Baker on the U.S. Economy, Lois Lerner's Language, Oil-Boom Airports and More 7:06 a.m. July 31, 2014 - The Wall Street Journal Interactive Edition
Johnson & Johnson Pulls Hysterectomy Tool From Hospitals 7:17 p.m. July 30, 2014 - The Wall Street Journal Interactive Edition
Merck, J&J, Baxter Provide Healthy Dividend Stream 6:01 p.m. July 30, 2014 - Investors Business Daily
Carlyle Group Swings to a Profit 5:36 p.m. July 30, 2014 - The Wall Street Journal Interactive Edition
Tax Inversion Puts These 3 Mutual Funds in Focus - Best of Funds 2:38 p.m. July 30, 2014 - Zacks.com
Pharma ETFs in Focus on String of Earnings Beat - ETF News And Commentary 2:00 p.m. July 30, 2014 - Zacks.com
Hospira Beats on Earnings and Sales in Q2, Boosts Guidance - Analyst Blog 11:26 a.m. July 30, 2014 - Zacks.com
Undervalued Biotech Stocks Beat the Index 10:42 a.m. July 30, 2014 - Barrons.com
Limiting Risk: A Little Exposure To High Yield Goes A Long Way 5:54 p.m. July 29, 2014 - GuruFocus.com
Top 3 MedTech Stocks, Poised to Gain on Earnings - Earnings ESP 11:38 a.m. July 29, 2014 - Zacks.com
3 Core Dividend Growth Stocks For Retirement Income 10:59 a.m. July 29, 2014 - Seeking Alpha
What's the Right PE Ratio? 9:06 a.m. July 29, 2014 - GuruFocus.com
3 Dividend Stocks Juicing Returns With Buybacks 4:53 a.m. July 29, 2014 - InvestorPlace.com
22 New Stocks to Watch – Mobileye, Synchrony Financial & More 4:49 a.m. July 29, 2014 - InvestorPlace.com
What's The Right PE Ratio? 4:43 a.m. July 29, 2014 - Seeking Alpha
CircleUp Announces Collaboration with Johnson & Johnson Innovation to Identify Transformative Consumer Companies 7:30 a.m. July 31, 2014 - Marketwire
Dendreon Names W. Thomas Amick President and Chief Executive Officer 4:04 p.m. July 30, 2014 - BusinessWire - BZX
Milestone Scientific Appoints Senior Healthcare Industry Executive Steven F. Robins as Marketing Consultant 7:32 a.m. July 30, 2014 - Marketwire
IBM Elects Two New Members to Its Board of Directors 4:34 p.m. July 29, 2014 - BusinessWire - BZX
Accelerator Corporation Secures $51.1 Million to Support Emerging Biotechnology Research Opportunities in New York City and Seattle 7:00 a.m. July 29, 2014 - BusinessWire - BZX
Global Aortic Stent Grafts Market 2014-2018 6:24 p.m. July 28, 2014 - PR Newswire - PRF
Global Non-Hodgkin Lymphoma Therapeutics Market 2014-2018 4:00 p.m. July 28, 2014 - PR Newswire - PRF
Decision Lens Secures $6.5 Million in Funding to Continue Record-Breaking Growth 12:21 p.m. July 24, 2014 - Marketwire
Abdominal Obesity Global Clinical Trials Review, H1, 2014 4:42 p.m. July 23, 2014 - PR Newswire - PRF
Global Markets for Catheters 3:21 p.m. July 23, 2014 - PR Newswire - PRF
Partial Seizure Global Clinical Trials Review, H2, 2014 1:53 p.m. July 23, 2014 - PR Newswire - PRF
Generalized Tonic-Clonic Seizure Global Clinical Trials Review, H2, 2014 1:24 p.m. July 23, 2014 - PR Newswire - PRF
Generalized Seizures Global Clinical Trials Review, H2, 2014 1:17 p.m. July 23, 2014 - PR Newswire - PRF
Financial Results, Campaign Launch, and New Steps in Facility Planning - Research Reports on Johnson & Johnson, Merck, AstraZeneca, Novartis and Teva 8:00 a.m. July 23, 2014 - PR Newswire - PRF
Johnson & Johnson Announces $5 Billion Share Repurchase Program 5:00 p.m. July 21, 2014 - PR Newswire - PRF
Johnson & Johnson Announces Quarterly Dividend for Third Quarter 2014 11:10 a.m. July 21, 2014 - PR Newswire - PRF
Technical Pointers on Pharma Equities -- AbbVie, Johnson and Johnson, Merck, Bristol-Myers Squibb, and Eli Lilly 8:40 a.m. July 21, 2014 - PR Newswire - PRF
Biotechnology Sector Trends Higher with Breakthrough Clinical Trials, Collaborations & License Agreements 8:15 a.m. July 16, 2014 - PR Newswire - PRF
Autism Global Clinical Trials Review, H1, 2014 1:00 p.m. July 15, 2014 - PR Newswire - PRF
The Hepatitis C Virus Drug-Treated Population in the G7 Markets Will Reach Nearly Half a Million Cases in 2016 10:00 a.m. July 15, 2014 - PR Newswire - PRF
J&J to call for voluntary return of morcellators 5:30 p.m. July 30, 2014 - MarketWatch.com
Chipotle tops S&P 500, Herbalife ignores ‘death blow’ 1:14 p.m. July 22, 2014 - MarketWatch
Johnson & Johnson sets $5 billion share buyback 5:20 p.m. July 21, 2014 - Jim Jelter
Two rules of thumb for dumping your financial adviser 2:36 p.m. July 18, 2014 - Mark Hulbert
Dow ekes out a gain, but S&P falls; Yellen knocks biotechs and social media: live blog recap 3:04 p.m. July 15, 2014 - blogs.marketwatch.com
Johnson & Johnson shares dip on cautious outlook 10:55 a.m. July 15, 2014 - blogs.marketwatch.com
Plug Power rallies; Lorillard drops on Reynolds merger 10:40 a.m. July 15, 2014 - Angela Johnson
Newscast: NBA wants to double TV fees 9:59 a.m. July 15, 2014 - MarketWatch
Johnson & Johnson tops forecasts, boosts outlook 7:57 a.m. July 15, 2014 - MarketWatch.com
Johnson & Johnson shares up 0.4% in premarket trade 7:51 a.m. July 15, 2014 - Tomi Kilgore
Johnson & Johnson sees full-year 2014 adjusted EPS of $5.85 to $5.92 7:50 a.m. July 15, 2014 - William L. Watts
Johnson & Johnson Q2 sales up 9.1% to $19.5 billion 7:49 a.m. July 15, 2014 - William L. Watts
Johnson & Johnson Q2 adjusted EPS $1.66 7:49 a.m. July 15, 2014 - William L. Watts
Johnson & Johnson Q2 EPS $1.51 vs. $1.33 a year earlier 7:47 a.m. July 15, 2014 - William L. Watts
The market in a minute: Earnings over politics 10:56 a.m. July 14, 2014 - The Trading Deck
Tech, bank earnings to test economic recovery 6:01 a.m. July 13, 2014 - Wallace Witkowski
Wal-Mart embracing smaller stores in growth strategy 4:05 a.m. July 8, 2014 - Shelly Banjo
How to buy momentum stocks without getting burned 9:22 a.m. July 7, 2014 - Jonathan Burton
What GM could gain from the recall of 29 million cars 4:54 a.m. July 4, 2014 - Tim Mullaney
Whistleblower to get millions for speaking up 8:00 a.m. June 25, 2014 - Al Lewis
Retirement Strategy: Buy The Dips Portfolio Update With Some Stocks On Sale 9:24 a.m. Today - Seeking Alpha
Dividend Investing Over The Past 7 Years Was Never Easy 12:14 a.m. Today - Seeking Alpha
NuVasive Running On Renewed MIS Vigor 12:04 p.m. July 31, 2014 - Seeking Alpha
Bayer Earnings Grow Marginally Y/Y, New Products Encourage - Analyst Blog 10:41 a.m. July 31, 2014 - Zacks.com
Why Johnson & Johnson (JNJ) Stock Is Lower Today 8:37 a.m. July 31, 2014 - TheStreet.com
The 10-Point: Gerard Baker on the U.S. Economy, Lois Lerner's Language, Oil-Boom Airports and More 7:06 a.m. July 31, 2014 - The Wall Street Journal Interactive Edition
Johnson & Johnson Pulls Hysterectomy Tool From Hospitals 7:17 p.m. July 30, 2014 - The Wall Street Journal Interactive Edition
Merck, J&J, Baxter Provide Healthy Dividend Stream 6:01 p.m. July 30, 2014 - Investors Business Daily
Carlyle Group Swings to a Profit 5:36 p.m. July 30, 2014 - The Wall Street Journal Interactive Edition
Tax Inversion Puts These 3 Mutual Funds in Focus - Best of Funds 2:38 p.m. July 30, 2014 - Zacks.com
Pharma ETFs in Focus on String of Earnings Beat - ETF News And Commentary 2:00 p.m. July 30, 2014 - Zacks.com
Hospira Beats on Earnings and Sales in Q2, Boosts Guidance - Analyst Blog 11:26 a.m. July 30, 2014 - Zacks.com
Undervalued Biotech Stocks Beat the Index 10:42 a.m. July 30, 2014 - Barrons.com
Limiting Risk: A Little Exposure To High Yield Goes A Long Way 5:54 p.m. July 29, 2014 - GuruFocus.com
Top 3 MedTech Stocks, Poised to Gain on Earnings - Earnings ESP 11:38 a.m. July 29, 2014 - Zacks.com
3 Core Dividend Growth Stocks For Retirement Income 10:59 a.m. July 29, 2014 - Seeking Alpha
What's the Right PE Ratio? 9:06 a.m. July 29, 2014 - GuruFocus.com
3 Dividend Stocks Juicing Returns With Buybacks 4:53 a.m. July 29, 2014 - InvestorPlace.com
22 New Stocks to Watch – Mobileye, Synchrony Financial & More 4:49 a.m. July 29, 2014 - InvestorPlace.com
What's The Right PE Ratio? 4:43 a.m. July 29, 2014 - Seeking Alpha
CircleUp Announces Collaboration with Johnson & Johnson Innovation to Identify Transformative Consumer Companies 7:30 a.m. July 31, 2014 - Marketwire
Dendreon Names W. Thomas Amick President and Chief Executive Officer 4:04 p.m. July 30, 2014 - BusinessWire - BZX
Milestone Scientific Appoints Senior Healthcare Industry Executive Steven F. Robins as Marketing Consultant 7:32 a.m. July 30, 2014 - Marketwire
IBM Elects Two New Members to Its Board of Directors 4:34 p.m. July 29, 2014 - BusinessWire - BZX
Accelerator Corporation Secures $51.1 Million to Support Emerging Biotechnology Research Opportunities in New York City and Seattle 7:00 a.m. July 29, 2014 - BusinessWire - BZX
Global Aortic Stent Grafts Market 2014-2018 6:24 p.m. July 28, 2014 - PR Newswire - PRF
Global Non-Hodgkin Lymphoma Therapeutics Market 2014-2018 4:00 p.m. July 28, 2014 - PR Newswire - PRF
Decision Lens Secures $6.5 Million in Funding to Continue Record-Breaking Growth 12:21 p.m. July 24, 2014 - Marketwire
Abdominal Obesity Global Clinical Trials Review, H1, 2014 4:42 p.m. July 23, 2014 - PR Newswire - PRF
Global Markets for Catheters 3:21 p.m. July 23, 2014 - PR Newswire - PRF
Partial Seizure Global Clinical Trials Review, H2, 2014 1:53 p.m. July 23, 2014 - PR Newswire - PRF
Generalized Tonic-Clonic Seizure Global Clinical Trials Review, H2, 2014 1:24 p.m. July 23, 2014 - PR Newswire - PRF
Generalized Seizures Global Clinical Trials Review, H2, 2014 1:17 p.m. July 23, 2014 - PR Newswire - PRF
Financial Results, Campaign Launch, and New Steps in Facility Planning - Research Reports on Johnson & Johnson, Merck, AstraZeneca, Novartis and Teva 8:00 a.m. July 23, 2014 - PR Newswire - PRF
Johnson & Johnson Announces $5 Billion Share Repurchase Program 5:00 p.m. July 21, 2014 - PR Newswire - PRF
Johnson & Johnson Announces Quarterly Dividend for Third Quarter 2014 11:10 a.m. July 21, 2014 - PR Newswire - PRF
Technical Pointers on Pharma Equities -- AbbVie, Johnson and Johnson, Merck, Bristol-Myers Squibb, and Eli Lilly 8:40 a.m. July 21, 2014 - PR Newswire - PRF
Biotechnology Sector Trends Higher with Breakthrough Clinical Trials, Collaborations & License Agreements 8:15 a.m. July 16, 2014 - PR Newswire - PRF
Autism Global Clinical Trials Review, H1, 2014 1:00 p.m. July 15, 2014 - PR Newswire - PRF
The Hepatitis C Virus Drug-Treated Population in the G7 Markets Will Reach Nearly Half a Million Cases in 2016 10:00 a.m. July 15, 2014 - PR Newswire - PRF
(0)
(0)